Lid worden?
Poll
Het is tijd voor de JGZ om bloeddruk te meten bij kinderen
Daily or Intermittent Budesonide in Preschool Children with Recurrent Wheezing
Bron: New England Journal of Medicine; 24 november, 2011
Background
Daily inhaled glucocorticoids are recommended for young children at risk for asthma exacerbations, as indicated by a positive value on the modified asthma predictive index (API) and an exacerbation in the preceding year, but concern remains about daily adherence and effects on growth. We compared daily therapy with intermittent therapy.
Methods
We studied 278 children between the ages of 12 and 53 months who had positive values on the modified API, recurrent wheezing episodes, and at least one exacerbation in the previous year but a low degree of impairment. Children were randomly assigned to receive a budesonide inhalation suspension for 1 year as either an intermittent high-dose regimen (1 mg twice daily for 7 days, starting early during a predefined respiratory tract illness) or a daily low-dose regimen (0.5 mg nightly) with corresponding placebos. The primary outcome was the frequency of exacerbations requiring oral glucocorticoid therapy.
Results
The daily regimen of budesonide did not differ significantly from the intermittent regimen with respect to the frequency of exacerbations, with a rate per patient-year for the daily regimen of 0.97 (95% confidence interval [CI], 0.76 to 1.22) versus a rate of 0.95 (95% CI, 0.75 to 1.20) for the intermittent regimen (relative rate in the intermittent-regimen group, 0.99; 95% CI, 0.71 to 1.35; P=0.60). There were also no significant between-group differences in several other measures of asthma severity, including the time to the first exacerbation, or adverse events. The mean exposure to budesonide was 104 mg less with the intermittent regimen than with the daily regimen.
Conclusions
A daily low-dose regimen of budesonide was not superior to an intermittent high-dose regimen in reducing asthma exacerbations. Daily administration led to greater exposure to the drug at 1 year.
Lees ook Medisch Contact: 2 december, 2011
Er zijn nog geen reacties bij dit bericht. Ziet u geen reactieformulier?
Personal Dashbord
U kunt een pagina samenstellen die u toegang geeft tot de vakinformatie en online hulpmiddelen die u belangrijk vindt.
Iets voor U?
-
Het is aantrekkelijk om nu aan te treden, want we staan aan het begin van het proces van de voorbereidingen voor de 6de studiedag.
-
Praktijktestperiode mei t/m juli 2012
-
Een prijs voor diegene die zich ingezet hebben om de JGZ in Nederland op een hoger plan te brengen
-
Aarzel niet en pak de kans om mee te kunnen denken en praten bij de AJN
Agenda
- 21 | 05 | 2012 Avondcyclus JGZ PAO Heyendael; epilepsie bij kinderen
- 23 | 05 | 2012 Sturen op vertrouwen
- 23 | 05 | 2012 1st European Conference on Child Abuse and Neglect
- 24 | 05 | 2012 Jongensbesnijdenis, KNMG standpunt in de praktijk
- 24 | 05 | 2012 Genetische testen, eerder, sneller, meer en…beter?
